Skip to content

Absci Corporation ABSI Additional Paid-In Capital

Additional Paid-In Capital at other companies

Schrodinger logo
SchrodingerSDGR
$1B+4.6%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$196.62M+16.6%
Zymeworks logo
ZymeworksZYME
$107.53M-30.3%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$4.38B+19.6%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+43.6%
Enterprise value$1.57B+73.1%
P/S855.5×+628×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's additional paid-in capital?
Absci Corporation (ABSI) reported additional paid-in capital of $826.04M in Q1 2026.
How has Absci Corporation's additional paid-in capital changed year-over-year?
Absci Corporation's additional paid-in capital increased by 12.4% year-over-year, from $734.71M to $826.04M.
What is the long-term trend for Absci Corporation's additional paid-in capital?
Over 5 years (2020 to 2025), Absci Corporation's additional paid-in capital has grown at a 318.3% compound annual growth rate (CAGR), from $635K to $813.63M.
What does additional paid-in capital mean?
This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.